Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
PUT
Allegiant Air
ALGT
$2.23B
| $222K | ﹤0.01% |
4,300
+2,000
| +87% | +$161K |
|
2802
CareDx
CDNA
$2.46B
| $222K | ﹤0.01% |
12,503
-12,286
| -50% | -$265K |
|
|
VMRK
2803
CALL
Vivmark Residential
VMRK
$25.5B
| $222K | ﹤0.01% |
+3,100
| New | +$219K |
|
2804
PUT
Wendy's
WEN
$1.69B
| $221K | ﹤0.01% |
+15,100
| New | +$227K |
|
2805
CALL
KB Home
KBH
$3.41B
| $221K | ﹤0.01% |
3,800
-12,600
| -77% | -$802K |
|
2806
CALL
Cardinal Health
CAH
$54B
| $220K | ﹤0.01% |
1,600
-10,300
| -87% | -$1.31M |
|
2807
iShares Biotechnology ETF
IBB
$10.7B
| $220K | ﹤0.01% |
+1,723
| New | +$234K |
|
2808
PUT
Allison Transmission
ALSN
$10.8B
| $220K | ﹤0.01% |
2,300
-4,400
| -66% | -$467K |
|
2809
PUT
PG&E
PCG
$39.9B
| $220K | ﹤0.01% |
+12,800
| New | +$212K |
|
2810
PUT
Rubrik
RBRK
$20.2B
| $220K | ﹤0.01% |
3,600
-9,000
| -71% | -$614K |
|
2811
CALL
Helmerich & Payne
HP
$4.25B
| $219K | ﹤0.01% |
+8,400
| New | +$244K |
|
2812
PUT
Zions Bancorporation
ZION
$9.91B
| $219K | ﹤0.01% |
+4,400
| New | +$237K |
|
2813
PUT
DoorDash
DASH
$99.3B
| $219K | ﹤0.01% |
+1,200
| New | +$226K |
|
|
SERV
2814
Serve Robotics
SERV
$405M
| $218K | ﹤0.01% |
+37,938
| New | +$498K |
|
2815
Relay Therapeutics
RLAY
$4.33B
| $218K | ﹤0.01% |
83,158
-3,199
| -4% | -$12.5K |
|
2816
Align Technology
ALGN
$11.3B
| $217K | ﹤0.01% |
+1,366
| New | +$268K |
|
2817
Direxion Daily Financial Bull 3x ETF
FAS
$2.44B
| $217K | ﹤0.01% |
+1,371
| New | +$226K |
|
2818
PUT
Textron
TXT
$14.1B
| $217K | ﹤0.01% |
3,000
-8,400
| -74% | -$629K |
|
2819
CALL
Oshkosh
OSK
$9.65B
| $216K | ﹤0.01% |
+2,300
| New | +$230K |
|
2820
Leslie's
LESL
$5.44M
| $216K | ﹤0.01% |
14,678
-17,543
| -54% | -$538K |
|
2821
PUT
Ryder
R
$9.39B
| $216K | ﹤0.01% |
+1,500
| New | +$234K |
|
2822
PUT
Texas Instruments
TXN
$236B
| $216K | ﹤0.01% |
1,200
-41,800
| -97% | -$7.83M |
|
2823
CALL
California Resources
CRC
$4.65B
| $215K | ﹤0.01% |
4,900
-500
| -9% | -$23.7K |
|
2824
PUT
East-West Bancorp
EWBC
$17.7B
| $215K | ﹤0.01% |
+2,400
| New | +$229K |
|
2825
PUT
Xylem
XYL
$26.7B
| $215K | ﹤0.01% |
+1,800
| New | +$223K |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.